Get started with SVB

Are you an innovation company or investor seeking banking services to help you move bold ideas forward, fast?

Let's get started

Existing SVB clients

Get quick answers from our support page.

For help with commercial cards

For other questions contact Client Service:


Find a location

Technical or site issue?

Trends in Neuro Device Investing



What’s happening in neuro device investing? In a new SVB sub-sector report we cover the private companies that are developing devices to treat neurological diseases, as well as non-neuro diseases in which the therapeutic effect is mediated through the nervous system.

Key insights from the report:

  • Financings increased by over 40 percent and invested equity grew by over 50 percent from 2016 to 2017.
  • Nervous system diseases — including pain, epilepsy and movement disorders, among others — represented the largest disease focus for neuro devices, capturing 40-45 percent of financings in both 2016 and 2017.
  • Significant early-stage investment took place, with 16 Seed and Series A financings raising more than $10 million each.

Download the report to learn more

About the Author

Bill Sideris is a Senior Associate with SVB Securities, conducting M&A advisory engagements involving early stage, venture-backed companies in the Healthcare and Life Sciences sectors. Prior to joining SVB Securities, Bill Sideris developed medical devices for ophthalmic and cardiovascular indications in both Fortune 500 and start-up organizations.

Bill Sideris graduated with a Professional Doctorate degree in engineering from the Technical University of Delft and a Master of Science degree in biomedical engineering from the University of Houston.
Now Let's Get Started

See how SVB makes next happen now for entrepreneurs like you.

Connect with Us